287 related articles for article (PubMed ID: 16842466)
1. Early treatment with ursodeoxycholic acid for cholestasis in children on parenteral nutrition because of primary intestinal failure.
De Marco G; Sordino D; Bruzzese E; Di Caro S; Mambretti D; Tramontano A; Colombo C; Simoni P; Guarino A
Aliment Pharmacol Ther; 2006 Jul; 24(2):387-94. PubMed ID: 16842466
[TBL] [Abstract][Full Text] [Related]
2. Ursodeoxycholic acid therapy for intractable total parenteral nutrition-associated cholestasis in surgical very low birth weight infants.
Al-Hathlol K; Al-Madani A; Al-Saif S; Abulaimoun B; Al-Tawil K; El-Demerdash A
Singapore Med J; 2006 Feb; 47(2):147-51. PubMed ID: 16435058
[TBL] [Abstract][Full Text] [Related]
3. Ursodeoxycholic acid (UDCA) therapy in very-low-birth-weight infants with parenteral nutrition-associated cholestasis.
Chen CY; Tsao PN; Chen HL; Chou HC; Hsieh WS; Chang MH
J Pediatr; 2004 Sep; 145(3):317-21. PubMed ID: 15343182
[TBL] [Abstract][Full Text] [Related]
4. Ursodiol in patients with parenteral nutrition-associated cholestasis.
San Luis VA; Btaiche IF
Ann Pharmacother; 2007 Nov; 41(11):1867-72. PubMed ID: 17911205
[TBL] [Abstract][Full Text] [Related]
5. [Cholestasis associated with prolonged parenteral nutrition in neonates: the role of urso-deoxycholic acid].
Garzón L; Ledo A; Cubells E; Sáenz P; Vento M
An Pediatr (Barc); 2009 Jun; 70(6):547-52. PubMed ID: 19443280
[TBL] [Abstract][Full Text] [Related]
6. Ursodeoxycholic acid treatment in preterm infants: a pilot study for the prevention of cholestasis associated with total parenteral nutrition.
Arslanoglu S; Moro GE; Tauschel HD; Boehm G
J Pediatr Gastroenterol Nutr; 2008 Feb; 46(2):228-31. PubMed ID: 18223390
[TBL] [Abstract][Full Text] [Related]
7. The biochemical and histopathological effects of ursodeoxycholic acid and metronidazole on total parenteral nutrition-associated hepatic dysfunction: an experimental study.
Günsar C; Melek M; Karaca I; Sencan A; Mir E; Ortaç R; Canan O
Hepatogastroenterology; 2002; 49(44):497-500. PubMed ID: 11995481
[TBL] [Abstract][Full Text] [Related]
8. Ursodeoxycholic acid in the treatment of cholestasis and hyperbilirubinemia in pediatric intensive care unit patients.
George R; Stevens A; Berkenbosch JW; Turpin J; Tobias J
South Med J; 2002 Nov; 95(11):1276-9. PubMed ID: 12539993
[TBL] [Abstract][Full Text] [Related]
9. Reversal of intestinal failure-associated liver disease in infants and children on parenteral nutrition: experience with 93 patients at a referral center for intestinal rehabilitation.
Cowles RA; Ventura KA; Martinez M; Lobritto SJ; Harren PA; Brodlie S; Carroll J; Jan DM
J Pediatr Surg; 2010 Jan; 45(1):84-7; discussion 87-8. PubMed ID: 20105585
[TBL] [Abstract][Full Text] [Related]
10. High rates of mortality and morbidity occur in infants with parenteral nutrition-associated cholestasis.
Willis TC; Carter BA; Rogers SP; Hawthorne KM; Hicks PD; Abrams SA
JPEN J Parenter Enteral Nutr; 2010; 34(1):32-7. PubMed ID: 19587385
[TBL] [Abstract][Full Text] [Related]
11. Ursodeoxycholic acid therapy in pediatric patients with progressive familial intrahepatic cholestasis.
Jacquemin E; Hermans D; Myara A; Habes D; Debray D; Hadchouel M; Sokal EM; Bernard O
Hepatology; 1997 Mar; 25(3):519-23. PubMed ID: 9049190
[TBL] [Abstract][Full Text] [Related]
12. Ursodeoxycholic acid therapy in children with cholestatic liver disease.
Dinler G; Koçak N; Yüce A; Gürakan F; Ozen H
Turk J Pediatr; 1999; 41(1):91-8. PubMed ID: 10770681
[TBL] [Abstract][Full Text] [Related]
13. Ursodeoxycholic acid administration in patients with cholestasis of pregnancy: effects on primary bile acids in babies and mothers.
Mazzella G; Rizzo N; Azzaroli F; Simoni P; Bovicelli L; Miracolo A; Simonazzi G; Colecchia A; Nigro G; Mwangemi C; Festi D; Roda E
Hepatology; 2001 Mar; 33(3):504-8. PubMed ID: 11230728
[TBL] [Abstract][Full Text] [Related]
14. Application of ursodeoxycholic acid (UDCA) in the therapy of liver and biliary duct diseases in children.
Lebensztejn DM
Med Sci Monit; 2000; 6(3):632-6. PubMed ID: 11208384
[TBL] [Abstract][Full Text] [Related]
15. Ursodeoxycholic acid for treatment of cholestasis in children on long-term total parenteral nutrition: a pilot study.
Spagnuolo MI; Iorio R; Vegnente A; Guarino A
Gastroenterology; 1996 Sep; 111(3):716-9. PubMed ID: 8780577
[TBL] [Abstract][Full Text] [Related]
16. Randomized prospective comparative study of ursodeoxycholic acid and S-adenosyl-L-methionine in the treatment of intrahepatic cholestasis of pregnancy.
Binder T; Salaj P; Zima T; Vítek L
J Perinat Med; 2006; 34(5):383-91. PubMed ID: 16965225
[TBL] [Abstract][Full Text] [Related]
17. Parenteral nutrition-associated cholestasis in preterm neonates: evaluation of ursodeoxycholic acid treatment.
Levine A; Maayan A; Shamir R; Dinari G; Sulkes J; Sirotta L
J Pediatr Endocrinol Metab; 1999; 12(4):549-53. PubMed ID: 10417972
[TBL] [Abstract][Full Text] [Related]
18. Rescue treatment of infants with intestinal failure and parenteral nutrition-associated cholestasis (PNAC) using a parenteral fish-oil-based lipid.
Cheung HM; Lam HS; Tam YH; Lee KH; Ng PC
Clin Nutr; 2009 Apr; 28(2):209-12. PubMed ID: 19261360
[TBL] [Abstract][Full Text] [Related]
19. Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome: clinical features and response to therapy.
Chazouillères O; Wendum D; Serfaty L; Montembault S; Rosmorduc O; Poupon R
Hepatology; 1998 Aug; 28(2):296-301. PubMed ID: 9695990
[TBL] [Abstract][Full Text] [Related]
20. Evidence that ursodeoxycholic acid prevents steroid-resistant rejection in adult liver transplantation.
Clavien PA; Sharara AI; Camargo CA; Harland RC; Fitz JG
Clin Transplant; 1996 Dec; 10(6 Pt 2):658-62. PubMed ID: 8996761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
